UBE2N Recombinant Antibody, PE-Cy5 Conjugated
Product Specifications
Background
The UBE2V1-UBE2N and UBE2V2-UBE2N heterodimers catalyze the synthesis of non-canonical 'Lys-63'-linked polyubiquitin chains. This type of polyubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation.
Synonyms
BLU; HEL-S-71; Ubc13; UbCH ben; UbcH13; UBCHBEN; Ube2n.
Gene ID
7334
Swiss Prot
P61088
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
UBE2N
Clonality
Recombinant
Conjugation
PE-Cy5
Source
KLH conjugated synthetic peptide derived from human UBE2N
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/670nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
7334
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
226646-01 50 µL
VEGFB (Vascular Endothelial Growth Factor B, VEGF-B, VEGF-Related Factor, VEGFB, VRF) discontinued
Ask
View Details 
226646-02 100 µL
VEGFB (Vascular Endothelial Growth Factor B, VEGF-B, VEGF-Related Factor, VEGFB, VRF) discontinued
Ask
View Details 
JH919825 1 Each
1H-Isoindole-4-carboxylic acid, 2- (2,6-dioxo-3-piperidinyl) -2,3-dihydro-1,3-dioxo-
Ask
View Details